Compare Public Storage (PSA) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Public Storage vs 10X Genomics Inc — how do they compare? Public Storage trades at $311.4 (market cap $54.39B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Public Storage is far larger — about 9.9× 10X Genomics Inc's market cap, and Public Storage pays a 3.87% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| PSA | TXG | |
|---|---|---|
Market Cap | $54.39B | $5.48B |
Sector | Real Estate | Health |
52-Week High | $329.64 | $47.20 |
52-Week Low | $258.44 | $11.34 |
Enterprise Value | $68.63B | $5.02B |
Dividend Yield | 3.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Public Storage (PSA) trades at $309.75, down 2.61% on the day, with a bearish technical signal but strong fundamentals including a 39.16% net income margin and consistent earnings beats. Recent developments include the pending acquisition of National Storage Affiliates and a $3.00 dividend payment scheduled for June 30, 2026. The stock is near its 52-week high of $331.00, reflecting investor confidence in its growth trajectory and sector leadership.
The outlook remains positive due to robust profitability, strategic expansions into Canada, and analyst consensus pointing to a $332.25 price target. Key risks include integration challenges from acquisitions and interest rate sensitivity. With 65.72% of analysts rating it Hold, the stock offers steady income potential but requires monitoring of execution risks and market volatility.
TXG trades at $47.20, up 7.91% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue that beat estimates, and net losses have narrowed significantly from -$255M in 2023 to -$44M in 2025. Operating cash flow turned strongly positive at $136M in 2025. Recent developments include the acquisition of Proteintech Genomics and a collaboration with Cleveland Clinic on bladder cancer diagnostics.
The outlook is mixed; improving fundamentals and strategic expansions support growth, but persistent net losses and a high EV/EBITDA of 133.91 pose valuation risks. Analyst consensus is divided with a $39.14 price target below the current price, indicating caution despite a majority buy/hold ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
